Taipei Exchange - Delayed Quote TWD

Anxo Pharmaceutical Co., Ltd. (6677.TWO)

16.05
-0.20
(-1.23%)
At close: 2:52:57 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
895,320
895,320
939,944
866,274
824,100
Cost of Revenue
569,838
569,838
543,010
534,816
492,441
Gross Profit
325,482
325,482
396,934
331,458
331,659
Operating Expense
381,906
381,906
343,781
325,248
291,812
Operating Income
-56,424
-56,424
53,153
6,210
39,847
Net Non Operating Interest Income Expense
-11,110
-11,110
-14,188
-13,542
-11,642
Pretax Income
-60,020
-60,020
38,680
-4,714
24,327
Tax Provision
-5,919
-5,919
7,882
2,327
4,586
Net Income Common Stockholders
-57,208
-57,208
21,861
-12,558
19,234
Diluted NI Available to Com Stockholders
-57,208
-57,208
21,861
-12,558
19,234
Basic EPS
-1.03
--
0.43
-0.26
0.39
Diluted EPS
-1.03
--
0.42
-0.26
0.39
Basic Average Shares
55,541.75
--
50,839.54
48,164
49,938.63
Diluted Average Shares
55,541.75
--
52,050
48,164
50,268.35
Total Expenses
951,744
951,744
886,791
860,064
784,253
Net Income from Continuing & Discontinued Operation
-57,208
-57,208
21,861
-12,558
19,234
Normalized Income
-57,073.69
-57,073.69
21,733.60
-12,346
19,031.13
Interest Income
5,569
5,569
3,887
1,651
1,120
Interest Expense
16,679
16,679
18,075
15,193
12,762
Net Interest Income
-11,110
-11,110
-14,188
-13,542
-11,642
EBIT
-43,341
-43,341
56,755
10,479
37,089
EBITDA
33,368
33,368
131,310
84,696
111,468
Reconciled Cost of Revenue
569,838
569,838
543,010
534,816
492,441
Reconciled Depreciation
76,709
76,709
74,555
74,217
74,379
Net Income from Continuing Operation Net Minority Interest
-57,208
-57,208
21,861
-12,558
19,234
Total Unusual Items Excluding Goodwill
-149
-149
160
-265
250
Total Unusual Items
-149
-149
160
-265
250
Normalized EBITDA
33,517
33,517
131,150
84,961
111,218
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-14.69
-14.69
32.60
-53
47.13
12/31/2021 - 6/27/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1780.TWO Allied Biotech Corporation
17.95
-0.55%
 
4166.TWO Orient Pharma Co., Ltd.
33.45
+1.36%
 
6932.TWO Mercury Biopharmaceutical Corporation
13.00
-0.38%
 
6483.TWO Original BioMedicals Co., Ltd.
12.05
+0.42%
 
7561.TWO Bioray Biotech Co., Ltd
21.15
-0.47%
 
6539.TWO DV Biomed Co., Ltd.
81.00
+2.27%
 
4117.TWO General Biologicals Corporation
15.50
+0.32%
 
6467.TWO TAHO Pharma
59.10
+3.50%
 
4172.TWO InnoPharmax Inc.
17.55
-2.23%
 
6621.TWO UniPharma Co., Ltd.
14.50
-0.68%